About Peter Olagunju
Form D filings for March Biosciences in 2024 list Peter Olagunju as director.
Peter Olagunju first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Olagunju in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peter Olagunju works with at each company, as listed on that company's latest Form D.
March Biosciences, Inc. · Form D, Oct 22, 2024
TL
Thomas Luby
Director
JP
Joseph Petrosino
Director
SH
Sarah Hein
Co-Founder, Chief Executive Officer and director
MM
Maksim Mamonkin
Executive officer and director